MiNK Therapeutics, Inc. - COM NEW (INKT)

CUSIP: 603693201

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COM NEW
Total 13F shares
91,313
Share change
+29,401
Total reported value
$1,278,548
Price per share
$14.00
Number of holders
18
Value change
+$420,748
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 603693201?
CUSIP 603693201 identifies INKT - MiNK Therapeutics, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INKT - MiNK Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AGENUS INC
3/4/5
10%+ Owner
class O/S missing
21,772,863
$22,643,778 12 Oct 2023
Garo H. Armen
3/4/5
Director
class O/S missing
1,966,400
$2,045,056 05 May 2023
VANGUARD GROUP INC
13F
Company
class O/S missing
23,744
$177,605 30 Jun 2025
13F
Longbow Finance SA
13F
Company
class O/S missing
16,667
$123,129 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
11,492
$85,976 30 Jun 2025
13F
Christine M. Klaskin
3/4/5
Treasurer
class O/S missing
55,660
$57,886 13 Oct 2021
BlackRock, Inc.
13F
Company
class O/S missing
7,421
$54,823 30 Jun 2025
13F
John Baldoni
3/4/5
Director
class O/S missing
41,193
$42,841 01 Sep 2023
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
849
$6,272 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
568
$4,196 30 Jun 2025
13F
TOTAL INVESTMENT MANAGEMENT INC
13F
Company
class O/S missing
500
$3,694 30 Jun 2025
13F
UBS Group AG
13F
Company
class O/S missing
284
$2,098 30 Jun 2025
13F
Covestor Ltd
13F
Company
class O/S missing
131
$1,000 30 Jun 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
120
$883 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
class O/S missing
32
$236 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
26
$192 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
class O/S missing
22
$163 30 Jun 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
class O/S missing
19
$140 30 Jun 2025
13F
Game Plan Financial Advisors, LLC
13F
Company
class O/S missing
16
$118 30 Jun 2025
13F
Clearstead Advisors, LLC
13F
Company
class O/S missing
14
$104 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
12
$89 30 Jun 2025
13F
Key FInancial Inc
13F
Company
class O/S missing
4
$30 30 Jun 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
class O/S missing
1
$7 30 Jun 2025
13F
Marc Antonius van Dijk
3/4/5
Chief Scientific Officer
class O/S missing
171,078
16 Jan 2024

Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q3 2025

As of 30 Sep 2025, MiNK Therapeutics, Inc. - COM NEW (INKT) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 91,313 shares. The largest 10 holders included VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, Covestor Ltd, and OSAIC HOLDINGS, INC.. This page lists 18 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
19
Q3 2025 holders
18
Holder diff
-1
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .